These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3656525)
1. Correlation of histopathological, cytological and flow cytometric findings in neoplastic and nonneoplastic lesions of the bladder. Cowan DF; Wu B; Young GP; Khanna OP J Urol; 1987 Oct; 138(4):753-7. PubMed ID: 3656525 [TBL] [Abstract][Full Text] [Related]
2. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. Giella JG; Ring K; Olsson CA; Karp FS; Benson MC J Urol; 1992 Aug; 148(2 Pt 1):293-6. PubMed ID: 1635121 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor. Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103 [TBL] [Abstract][Full Text] [Related]
4. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Badalament RA; Hermansen DK; Kimmel M; Gay H; Herr HW; Fair WR; Whitmore WF; Melamed MR Cancer; 1987 Oct; 60(7):1423-7. PubMed ID: 3304614 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases. Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514 [TBL] [Abstract][Full Text] [Related]
6. Ancillary techniques in the followup of transitional cell carcinoma: a comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. Mora LB; Nicosia SV; Pow-Sang JM; Ku NK; Diaz JI; Lockhart J; Einstein A J Urol; 1996 Jul; 156(1):49-54; discussion 54-5. PubMed ID: 8648836 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437 [TBL] [Abstract][Full Text] [Related]
8. Urine or bladder washings in the cytologic evaluation of transitional cell carcinoma of the urinary tract. A comparison made under routine conditions supplemented by flow cytometric DNA analysis. Wijkström H; Lundh B; Tribukait B Scand J Urol Nephrol; 1987; 21(2):119-23. PubMed ID: 3616503 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors. Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500 [TBL] [Abstract][Full Text] [Related]
10. [A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma]. Tachibana M; Jitsukawa S; Tazaki H; Tashiro Y Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1025-30. PubMed ID: 2607716 [TBL] [Abstract][Full Text] [Related]
11. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
12. [Clinical application of flow cytometry in urology. 3. Correlation between urinary cytology and flow cytometry]. Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1864-7. PubMed ID: 3573470 [No Abstract] [Full Text] [Related]
13. Flow cytometry deoxyribonucleic acid determinations and cytology of bladder washings: practical experience. Klein FA; White FK J Urol; 1988 Feb; 139(2):275-8. PubMed ID: 3339724 [TBL] [Abstract][Full Text] [Related]
14. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples. Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493 [TBL] [Abstract][Full Text] [Related]
15. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Whisnant RE; Bastacky SI; Ohori NP Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and cytology as response indicators to M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Hermansen DK; Reuter VE; Whitmore WF; Fair WR; Melamed MR J Urol; 1988 Dec; 140(6):1394-6. PubMed ID: 3193503 [TBL] [Abstract][Full Text] [Related]
17. Urine cytology in bladder tumors. Zein TA; Milad MF Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253 [TBL] [Abstract][Full Text] [Related]
18. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429 [TBL] [Abstract][Full Text] [Related]